# Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer

> **NCT01969032** · PHASE2 · COMPLETED · sponsor: **Russian Academy of Medical Sciences** · enrollment: 41 (actual)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **DRUG:** Paclitaxel, Carboplatinum, Doxorubicin, Endoxan, Capecitabine

## Key facts

- **NCT ID:** NCT01969032
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01969032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01969032, "Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01969032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*